Charles River Laboratories International, Inc. (CRL) DCF Valuation

Charles River Laboratories International, Inc. (CRL) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Charles River Laboratories International, Inc. (CRL) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Assess the financial outlook of Charles River Laboratories International, Inc. (CRL) with expert precision! This (CRL) DCF Calculator provides pre-filled financial data along with the flexibility to modify revenue growth, WACC, margins, and other essential assumptions to align with your predictions.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 2,621.2 2,923.9 3,540.2 3,976.1 4,129.4 4,633.1 5,198.3 5,832.4 6,543.9 7,342.1
Revenue Growth, % 0 11.55 21.08 12.31 3.86 12.2 12.2 12.2 12.2 12.2
EBITDA 581.7 759.1 854.3 1,035.9 1,032.1 1,142.8 1,282.3 1,438.7 1,614.2 1,811.1
EBITDA, % 22.19 25.96 24.13 26.05 24.99 24.67 24.67 24.67 24.67 24.67
Depreciation 198.1 234.9 265.5 303.9 314.1 355.3 398.6 447.3 501.8 563.0
Depreciation, % 7.56 8.03 7.5 7.64 7.61 7.67 7.67 7.67 7.67 7.67
EBIT 383.6 524.2 588.8 732.0 718.0 787.6 883.6 991.4 1,112.4 1,248.0
EBIT, % 14.64 17.93 16.63 18.41 17.39 17 17 17 17 17
Total Cash 238.0 228.4 241.2 233.9 276.8 336.3 377.3 423.3 475.0 532.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 514.0 617.7 642.9 752.4 780.4
Account Receivables, % 19.61 21.13 18.16 18.92 18.9
Inventories 160.7 185.7 199.1 255.8 380.3 312.7 350.9 393.7 441.7 495.6
Inventories, % 6.13 6.35 5.63 6.43 9.21 6.75 6.75 6.75 6.75 6.75
Accounts Payable 111.5 122.5 198.1 205.9 168.9 216.0 242.3 271.9 305.1 342.3
Accounts Payable, % 4.25 4.19 5.6 5.18 4.09 4.66 4.66 4.66 4.66 4.66
Capital Expenditure -140.5 -166.6 -228.8 -324.7 -318.5 -309.5 -347.2 -389.6 -437.1 -490.5
Capital Expenditure, % -5.36 -5.7 -6.46 -8.17 -7.71 -6.68 -6.68 -6.68 -6.68 -6.68
Tax Rate, % 18.35 18.35 18.35 18.35 18.35 18.35 18.35 18.35 18.35 18.35
EBITAT 318.0 427.1 478.9 571.3 586.2 638.5 716.4 803.8 901.9 1,011.9
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -187.7 377.7 552.7 392.1 392.4 683.1 646.7 725.6 814.1 913.4
WACC, % 9.19 9.17 9.17 9.13 9.17 9.17 9.17 9.17 9.17 9.17
PV UFCF
SUM PV UFCF 2,888.4
Long Term Growth Rate, % 3.00
Free cash flow (T + 1) 941
Terminal Value 15,255
Present Terminal Value 9,839
Enterprise Value 12,727
Net Debt 2,790
Equity Value 9,938
Diluted Shares Outstanding, MM 51
Equity Value Per Share 193.15

What You Will Get

  • Real CRL Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Charles River Laboratories International, Inc. (CRL).
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates to fit your analysis needs.
  • Instant Valuation Updates: Automatic recalculations to assess the impact of changes on CRL’s fair value.
  • Versatile Excel Template: Designed for quick edits, scenario testing, and comprehensive projections.
  • Time-Saving and Accurate: Avoid the hassle of building models from scratch while ensuring precision and flexibility.

Key Features

  • Comprehensive Historical Data: Access to Charles River Laboratories' (CRL) past financial statements and projected forecasts.
  • Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Valuation: Watch the intrinsic value of Charles River Laboratories (CRL) update instantly.
  • Intuitive Visual Representations: Dashboard graphs showcase valuation outcomes and essential metrics.
  • Designed for Precision: A reliable tool tailored for analysts, investors, and finance professionals.

How It Works

  • Download: Access the ready-to-use Excel file with Charles River Laboratories' (CRL) financial data.
  • Customize: Adjust forecasts, including revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations update in real-time.
  • Test Scenarios: Create multiple projections and compare outcomes instantly.
  • Make Decisions: Use the valuation results to guide your investment strategy.

Why Choose This Calculator?

  • Accurate Data: Real Charles River Laboratories International, Inc. (CRL) financials ensure reliable valuation results.
  • Customizable: Adjust key parameters like growth rates, WACC, and tax rates to match your projections.
  • Time-Saving: Pre-built calculations eliminate the need to start from scratch.
  • Professional-Grade Tool: Designed for investors, analysts, and consultants.
  • User-Friendly: Intuitive layout and step-by-step instructions make it easy for all users.

Who Should Use This Product?

  • Investors: Accurately assess the fair value of Charles River Laboratories International, Inc. (CRL) before making investment decisions.
  • CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to CRL.
  • Consultants: Easily customize the template for valuation reports tailored to clients interested in CRL.
  • Entrepreneurs: Discover insights into financial modeling practices employed by leading firms like Charles River Laboratories (CRL).
  • Educators: Implement it as a teaching resource to illustrate valuation methodologies relevant to CRL.

What the Template Contains

  • Pre-Filled DCF Model: Charles River Laboratories' (CRL) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Charles River Laboratories' (CRL) profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.